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Background: The Bacillus subtilis genome (BGM) vector is a novel cloning system for large DNA fragments, in
which the entire 4.2 Mb genome of B. subtilis functions as a vector. The BGM vector system has several attractive
properties, such as a large cloning capacity of over 3 Mb, stable propagation of cloned DNA and various
modification strategies using RecA-mediated homologous recombination. However, genetic modifications using the
BGM vector system have not been fully established, and this system has not been applied to transgenesis. In this
study, we developed important additions to the genetic modification methods of the BGM vector system. To
explore the potential of the BGM vector, we focused on the fish-like odorant receptor (class I OR) gene family,
which consists of 158 genes and forms a single gene cluster. Although a cis-acting locus control region is expected
to regulate transcription, this has not yet been determined experimentally.
Results: Using two contiguous bacterial artificial chromosome clones containing several class I OR genes, we
constructed two transgenes in the BGM vector by inserting a reporter gene cassette into one class I OR gene. Because
they were oriented in opposite directions, we performed an inversion modification to align their orientation and then
fused them to enlarge the genomic structure. DNA sequencing revealed that no mutations occurred during gene
manipulations with the BGM vector. We further demonstrated that the modified, reconstructed genomic DNA
fragments could be used to generate transgenic mice. Transgenic mice carrying the enlarged transgene recapitulated
the expression and axonal projection patterns of the target class I OR gene in the main olfactory system.
Conclusion: We offer a complete genetic modification method for the BGM vector system, including insertion,
deletion, inversion and fusion, to engineer genomic DNA fragments without any trace of modifications. In addition, we
demonstrate that this system can be used for mouse transgenesis. Thus, the BGM vector system can be an alternative
platform for engineering large DNA fragments in addition to conventional systems such as bacterial and yeast artificial
chromosomes. Using this system, we provide the first experimental evidence of a cis-acting element for a class I OR
gene.Background
Technological developments in chromosome engineer-
ing are essential for the manipulation and functional
analysis of genomic DNA fragments. Artificial chromo-
somes, such as bacterial artificial chromosomes (BACs)
[1] and yeast artificial chromosomes (YACs) [2], have* Correspondence: jhirota@bio.titech.ac.jp
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reproduction in any medium, provided the orbeen used for these purposes in combination with
transgenesis. BAC and YAC transgenesis techniques
have contributed greatly to genome research. However,
there are several technological limitations in their clon-
ing size, genetic modification and insert stability. BAC
clones are easy to manipulate and retrieve due to their
plasmid form and the stability of the cloned DNA. The
methods for modifying BAC inserts require additional
recombination components, e.g., RecA or phage-derived
recombination proteins [3-6]. The BAC system can
generally accommodate up to 300 kb genomic inserts. In
contrast to the BAC system, genomic DNA inserts of uptd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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inserts can be easily modified by homologous recombin-
ation, YACs often suffer from insert chimerism and un-
wanted rearrangements due to potent and constitutive
yeast recombination activity [7,8]. Generally, the isola-
tion of intact YACs is difficult because of their linear
form and contamination with endogenous yeast chromo-
somes. Thus, these two systems have complementary
advantages over each other in terms of cloning capacity
and insert stability.
The Bacillus subtilis genome (BGM) vector system has
been developed as a novel cloning system using a unique
concept in which the entire 4.2 Mb genome of B. subtilis
functions as a vector [9-12]. The cloning strategy for this
vector system is based on unique B. subtilis features
[13,14]. B. subtilis expresses competence-related genes at
the late stage of cell growth, and their products, trans-
formation machinery molecules, are assembled in the
cell membrane. The transformation machinery non-
specifically binds and imports extracellular DNA frag-
ments into the cytoplasm in single-stranded form. The
recombinogenic DNA is incorporated into the B. subtilis
genome by homologous recombination. Therefore, if the
B. subtilis genome is engineered to have homologous
cloning site sequences, a target DNA fragment flanked
by homologous sequences is easily cloned into the BGM.
Special handling of the BGM vector system is not
required [12]. B. subtilis can be cultivated under the
same conditions as Escherichia coli in LB broth at 37°C.
The competency of B. subtilis enables easy transform-
ation procedures and efficient recombination reactions.
For instance, competent B. subtilis cells can be prepared
by merely cultivating the cells in a special medium for
several hours, and these cells are transformed by simply
mixing in DNA fragments without additional heat-shock
or electroporation [12].
The specific features of the BGM vector system in-
clude a cloning capacity over 3 Mb [15], the stable
propagation of cloned DNA fragments in a single copy
per cell and the amenability of various modification
strategies based on RecA-mediated homologous recom-
bination [10,16,17]. These advantages make the BGM
vector system an attractive alternative for the manipula-
tion of large DNA. It has been used to clone genomic
DNA from several species, including cyanobacteria [15],
Arabidopsis [10] and mouse [17,18]. Modifications
consisting of deleting and fusing cloned inserts have also
been achieved [16,17]. However, genetic modification
methods have not been fully established in the BGM
vector system; targeted insertion and inversion modifica-
tions remain to be demonstrated, and the fusion of two
contiguous DNA fragments is limited to clones that are
orientated in the same direction. In addition, the BGM
system has not been applied to transgenesis. Thus, theBGM vector system is a developing technology with
attractive potential, which includes its megabase-cloning
capacity and homologous recombination-based genetic
modification.
In this study, we have added two new genetic modifi-
cations to the BGM system tool kit. One is targeted
insertion of a reporter gene without introducing an
unwanted selectable marker at the target site when
constructing the transgene. Another is inversion of the
cloned insert to align its orientation so that two contigu-
ous BAC clones in opposite directions can be used to re-
construct the genomic structure. In fact, inversion of a
cloned insert has not been reported in any other system.
To explore the potential utility of the BGM vector in
mouse transgenesis, we focused on the fish-like odorant
receptor (class I OR) gene family. This OR family is a
phylogenetically ancient mammalian OR family [19].
The mouse class I OR gene family consists of 158 genes,
forming an approximately 3 Mb gene cluster [20,21].
Although a cis-acting locus control region is expected to
regulate transcription, such a region has not been found.
In this study, we not only demonstrated the ability to
use the BGM vector system to manipulate and recon-
struct mouse genomic DNA fragments and perform
mouse transgenesis (Figure 1), but we also found evi-
dence of a cis-acting regulatory element for class I OR
gene expression.
Results
Cloning of genomic DNA fragments into the BGM vector
Mouse genomic BAC libraries have been constructed
that cover nearly the entire mouse genome, and each
clone contains a genomic DNA fragment with an aver-
age size of approximately 150 kb [22]. The BGM vector
system can utilize these valuable DNA resources in a
one-step transfer [10]. We prepared two BAC clones,
designated BAC1 and BAC2, which overlapped each
other via 82 kb region and carried 114 kb and 220 kb
mouse genomic DNA fragments containing two and ten
class I OR genes, respectively (Figure 2A). We trans-
ferred these BAC inserts into BGM vectors, which har-
bor BAC vector sequences, to clone the BAC inserts by
homologous recombination (Figure 1A) [10,16]. Briefly,
the original BGM vector is resistant to spectinomycin
(Spc) and sensitive to neomycin (Nm) due to repression
of the Pr-neo cassette by the CI repressor. The BAC in-
serts taken up by the B. subtilis are integrated directly
into the genome (BGM vector) via double crossings-over
recombination with the BAC vector sequences of the
BGM vector. Once a BAC insert is cloned into the BGM
vector, the recombinants become resistant to Nm and sen-
sitive to Spc, because the BAC insert replaces the cI-spc
cassette. This selection mechanism can be used in cI
cassette-mediating modifications, such as the targeted
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Figure 1 (See legend on next page.)
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Figure 1 Cloning and various modification methods of the BGM vector system in the generation of transgenic mice. (A) The cloning
strategy used to introduce BAC inserts into the BGM vector (Figure 2). BGM vectors possess two antibiotic gene cassettes: Pr-neo, a lambda Pr
promoter fused to the neomycin resistance gene (neo), and cI-spc, which contains cI encoding the CI repressor protein, which binds to the Pr
promoter, fused to the spectinomycin resistance gene (spc). The cI-spc is flanked by two BAC vector sequences that function as the cloning site
for BAC inserts. The original BGM strains are resistant to Spc and sensitive to Nm. Once a BAC insert is cloned into the BGM vector, the
recombinant becomes resistant to Nm and sensitive to Spc because the cI-spc cassette is replaced by the BAC insert. (B) Modifications of large
DNA fragments. The BGM vector system allows various manipulations, including insertion (e.g., EGFP is designated as “G” in the box) (Figure 3),
deletion and the inversion (Figure 4) and fusion of two overlapping clones (Figure 5). (C) The BGM inserts can be retrieved by several methods,
and the recombinant DNA fragments can be used for the generation of transgenic animals by microinjection (Figure 6). The closed triangles
represent a target gene and its direction. The BAC vector sequences are indicated by the closed and open arrows. The half part of BAC vector
containing chloramphenicol resistance gene for E. coli is depicted by open arrow (defined as right side). The I-PpoI sites, designated as “I” are
introduced to flank the BAC vector sequences. The deletion method is described in [17].
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http://www.biomedcentral.com/1471-2164/14/300insertion technique. Because two 23-bp sequences
“ATGACTCTCTTAA/GGTAGCCAAA” recognized by
the rare-cutting endonuclease, I-PpoI are introduced at
the both sides of the BAC cloning site, I-PpoI digestion
enables to excise out the cloned insert from the BGM vec-
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Figure 2 Cloning of BAC inserts into the BGM vector. (A) Genomic stru
study. The BAC clones cover a portion of the class I OR locus on chromoso
directions in the BAC vector. A large triangle depicts MOR42-3, black triang
pseudo-OR gene [20]. (B, C) The cloning of BAC1 and BAC2 into the BGM v
Southern blotting (right panels in B and C). The representative BGM vector
and resolved by CHEF. The open arrowheads indicate BAC insert bands, an
clones and genomic DNA from representative BGM clones were digested w
probes. The BGM recombinants showed a band pattern identical to the ori
the BAC end sequences from EcoRI-digested BAC1; the closed arrowhead i
specific signals from EcoRI-digested BAC1. In other digestion patterns, the
indistinguishable from insert signals predicted from restriction maps of BAC
numbers. In lane M, lambda/HindIII fragments or a lambda DNA concatemDNA of the recombinant vectors with I-PpoI followed by
contour-clamped homologous electric field (CHEF) gel
electrophoresis (Figure 2B, C). Three of seven candidate
clones (resistant to Nm and sensitive to Spc) in BAC1 and
one of 29 candidate clones in BAC2 contained BAC in-
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les indicate other OR genes, and the gray triangle represents the
ector was confirmed by I-PpoI/CHEF (left panels in B and C) and
s with transferred BAC1 and BAC2 inserts were digested with I-PpoI
d the closed arrowheads indicate the BGM vector. Purified original BAC
ith EcoRI or HindIII and hybridized with the original BAC clones as
ginal BAC clones (lane: BAC), except for the bands corresponding to
ndicates a BAC-specific signal, and the open arrowheads indicate BGM-
bands of the BAC end sequences were overlapping and
clones and the BGM vector. Numbers above lanes are the BGM clone
er was used as a size marker.
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file 1). We cloned 10 different BAC clones with 3 to 100%
efficiency (average 40%). The cloned inserts were further
confirmed by Southern blot analyses using the original
BAC clones as probes; the results indicated that the digest
patterns of the BGM recombinants were identical to those
of the original BAC clones, except for the fragments de-
rived from the ends of the insert (Figure 2B, C). Thus, the
BGM vector system imported the BAC insert by simple
transformation, which enabled the use of already
established valuable BAC resources.
Targeted insertion of a reporter gene
To construct transgenes for the analysis of cis-acting ele-
ments of class I OR genes, we inserted an IRES-tauEGFP
reporter gene cassette [23], which consisted of an in-
ternal ribosome entry site and the tauEGFP fusion pro-
tein coding sequence, into the class I OR gene MOR42-3
locus by two-step recombination using the cI-spc cas-
sette (Figure 3A). In the first step, the BGM clones
containing the BAC inserts were transformed with a re-
porter cassette with the selection marker cI-spc flanked
by 1.0 kb homology regions to the target OR locus (L
and R arms) to generate Tg-110CISP and Tg-220CISP.
Four of 15 Spc-resistant Tg-110CISP clones and six of
15 Spc-resistant Tg-220CISP clones were sensitive to
Nm. In the second step, the counterselection was
performed to remove selection marker using a reporter
gene cassette without a cI-spc cassette to generate two
transgenes, Tg-110 and Tg-220. Nm-resistant and Spc-






















Figure 3 Targeted insertion of a reporter gene. (A) In the first step, IRES
MOR42-3 stop codon by transformation with a purified DNA fragment cons
cI-spc selection cassette. In the second step, the selection cassette was rem
(B) The targeted insertion of the reporter gene was confirmed by Southern
DNA of each BGM clone was digested with BamHI and resolved by CHEF, a
expected, indicating the successful targeted insertion of IRES-tauEGFP. The
sites are represented by “B”. Lane M, lambda/HindIII fragments were used aregion between EGFP and R arm. The cI-spc cassettes
were correctly removed in four of 15 tested clones for
Tg-110 and two of 48 clones for Tg-220. Negative clones
were no PCR product, suggesting that insert DNA se-
quences had been also deleted along with the cI-spc cas-
settes. Relatively low success of the recombination
events in the counterselection was previously reported
in the BGM system [18] as well as the BAC system [6].
Accordingly, two transgenes, Tg-110 and Tg-220, which
were derived from BAC1 and BAC2, respectively, were
constructed by inserting IRES-tauEGFP 3 bp down-
stream of the MOR42-3 stop codon. Southern blot ana-
lysis of representative clones with the R arm probe
indicated the correct insertion of the reporter cassette
(Figure 3B). Thus, we established a targeted insertion
method using the BGM vector system with homologous
recombination using several antibiotic resistance genes
and the cI gene without leaving any trace of selection
markers or site-specific recombination sites, such as
loxP and FRT, in the target sequence (Figure 1B) [5,6].
Inversion of the insert in the BGM vector
Tg-110 and Tg-220 shared approximately 82 kb of over-
lapping sequence (Figure 2A), which would enable the
fusion of these two fragments to create a longer trans-
genic construct in the BGM vector system if the two
clones were cloned in the same direction. This technique
extends one insert by homologous recombination be-
tween the overlapping region of another insert and the
common vector region [16]. However, the Tg-110 and







































-tauEGFP was inserted into the targeted site 3 bp downstream of the
isting of L and R arms (1.0 kb each) homologous to MOR42-3 and the
oved by transformation with a fragment lacking the selection marker.
blot analysis using an R homology region as a probe. The genomic
nd the changes in the sizes of the BamHI fragments were as
sensitivity to antibiotics is shown. R, resistant; S, sensitive. The BamHI
s a size marker.
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http://www.biomedcentral.com/1471-2164/14/300BGM vector. In this case, the two clones could not be
used to extend the insert by the double crossing-over re-
combination. Insert inversion techniques have not been
reported in the BGM or other conventional systems. To
fuse these two fragments, we first inverted the Tg-110
insert to orient it in the same direction as Tg-220 using
two incomplete fragments of the tetracycline resistance
gene (tet), te (5′ side) and et (3′ side), which shared an
approximately 1.1 kb overlap region designated e [24].
The erythromycin resistance (erm) and phleomycin re-
sistance (phl) genes were added as selection markers to
the te and et fragments, respectively. The two inversion
cassettes, te-erm and phl-et, were sequentially inserted at
the ends of the Tg-110 insert in the reverse direction
(Figure 4A). Briefly, phl-et cassette was inserted to the
right end of the Tg-110 insert by transforming Tg-110
with the linearized BAC plasmid containing the phl-et
cassette and a 0.8 kb homology region. The phl-et cas-
sette was inserted in all five Phl-resistant clones assessed
by PCR. Subsequently, we inserted the te-erm to the left
end of the insert using the linearized BAC plasmid
containing the te-erm cassette with a 0.9 kb homology
region, and obtained Tg-110 T/P (1 clone/1 tested).
Intrachromosomal homologous recombination between
te and et via the overlapping region e (Tg-110 T/P)
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Figure 4 Inversion of the Tg-110 insert. (A) Schematic diagram of invers
gene (tet), te (5′ side) and et (3′ side), which contained an overlapping regio
of et and the phleomycin resistance gene (phl), and te-erm, consisting of te
inserted into the ends of the Tg-110 insert. A 0.9 kb fragment in the left en
arms. Homologous recombination between te and et in Tg-110 T/P results
positions of BamHI sites are represented by “B”. (B) Inversion was confirmed
DNA of the represented clones was digested with BamHI. Changes in the s
intrachromosomal homologous recombination. The open (2.8 kb te-erm ca
erm-e-phl cassette and 1.6 kb tet plus 2.7 kb Tg-110 fragment) arrowheadsof a complete tet gene, enabling the selection of the
inverted clone (Tg-110-Inverted) using Tet (Figure 4A).
We obtained over 100 Tet-resistant colonies from 20 μl
of Tg-110 T/P overnight culture. The formation of tet
and erm-e-phl cassettes was confirmed by PCR in all
four randomly picked clones from these colonies. As
expected, Southern blot analysis using a tet probe re-
vealed changes in size of the tet cassette fragments, indi-
cating the successful inversion of the Tg-110 insert
(Figure 4B). Because the direction of the inserts is not
coordinated in the BAC library, the inversion technique
for insert fragments is essential to fuse and reconstruct
genomic structures using BAC clones.
Fusing two inserts to reconstruct genomic structures
We then fused Tg-220 and the inverted Tg-110 to en-
large the mouse genomic DNA fragment (Figure 5A).
The cI-spc and cI-bsr marker gene cassettes were
inserted into the left end of the Tg-220 insert and the
right end of the inverted Tg-110 insert, respectively. We
transformed Tg-220 with the linearized BAC plasmid
containing the cI-spc and a 1.3 kb homology region, and
obtained Tg-220CISP clones (9 clones from 10 Spc-
resistant clones). Tg-110-Inverted was similarly transformed
with the cI-bsr cassette fragment containing a 1.3 kb hom-
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in the inversion of the insert to form an intact tet gene. The about
by Southern blotting using the tet gene as a probe. The genomic
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Figure 5 The genetic fusion of the inverted Tg-110 and Tg-220 fragments to reconstruct the genomic structure of the MOR42-3 locus.
(A) Schematic diagram of fusion of Tg-110-Inverted and Tg-220 fragments. The selection marker cassettes cI-bsr, consisting of the cI and
blasticidin S resistance genes (depicted as cB), and cI-spc (depicted as cS) were inserted to the right end of the inverted Tg-110 and to the left
end of Tg-220, respectively. 1.3 kb fragments in the left end of Tg-220 and in the right end of Tg-110-Inverted were used as homology arms.
Genomic DNA was isolated from the bsr-labeled Tg-110 clone (Tg-110CIBS) and added to the spc-labeled Tg-220 competent cells (Tg-220CISP).
The Tg-220 insert was extended to 252 kb by homologous recombination at the overlap region. (B) The fused Tg-250SB insert was evaluated by
I-PpoI digestion followed by CHEF. Tg-250SB shows a larger band that corresponds to the fused insert fragment. The closed and open
arrowheads represent bands from the 4.2 Mb BGM vector and inserts, respectively. (C) The structure of the Tg-250SB insert was confirmed by
Southern blot analysis. Genomic DNA was digested with EcoRI and hybridized with Tg-110 and Tg-220 probes. The genetic fusion of the two
inserts is shown as the sum of the respective Tg-250SB bands. The I-PpoI sites are represented by “I”. Lane M, lambda/HindIII fragments or a
concatemer of lambda DNA was used as a size marker.
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http://www.biomedcentral.com/1471-2164/14/300from 2 Bs-resistant clones). The two transgenes were fused
by genetic transformation of Tg-220CISP with the purified
genomic DNA of Tg-110CIBS. Homologous recombination
of the 82 kb overlapping region and the common se-
quence of the BGM vectors resulted in the extension
of the insert to generate Tg-250SB. Twenty-six of 29
Spc- and Bs-resistant colony recombinants were sensitive to
Nm. We selected two representative clones for further
examinations. The two Tg-250SB clones turned to be sensi-
tive to Tet, whose resistance gene exists in the left end of
the Tg-110-Inverted insert and was removed by the fusion,
suggesting correct recombination occurs to extend the in-
sert. I-PpoI/CHEF analyses of the Tg-250SB genomic DNA
demonstrated a larger band corresponding to the 252 kb
fused insert fragment (Figure 5B). Southern blot analysis
showed that Tg-250SB was composed of two transgenes,
Tg-220 and Tg-110 (Figure 5C), indicating that the two
inserts were successfully fused to extend the insert size.
DNA sequencing of modified and reconstructed BGM clones
To verify the reliability of the BGM vector system in ma-
nipulating genomic DNA fragments and its accuracy in
genetic engineering, we performed DNA sequencing of
the original BAC clones (BAC1 and BAC2), the modifiedBGM clones (Tg-110CIBS and Tg-220CISP) and the
fused BGM clone (Tg-250SB). The read mapping results
are summarized in Table 1. No mutation was observed
in the cloned and modified mouse genomic inserts dur-
ing manipulations of the BGM vector, and all targeted
modifications were accurately introduced. A few nucleo-
tides differed from the reference sequence data in both
BAC1 and BAC2. Two single-nucleotide differences
were found between BAC1 and the reference sequence
[GenBank: AC132096.4]: the replacement of G at posi-
tions 10349 and 113530 by A and T, respectively. Four
differences were found between BAC2 and the reference
data [GenBank: AC102535.17]: G at 210780, G at
210788, A at 210815 and G at 210840 were replaced by A,
A, G and A, respectively. Therefore, starting from targeted
insertion, all possible genetic modifications, i.e., insertion,
deletion, inversion and fusion to the targeted site, could
now be introduced using the BGM system without leaving
unnecessary sequences in the insert DNA.
Generation of BGM transgenic mice
Other cloning tools for large DNA fragments, such as
BACs and YACs, in combination with transgenesis, have
greatly contributed to life science research, including
Table 1 Summary of the read mapping in DNA sequencing
BAC1 BAC2 Tg110CIBS Tg220CISP Tg250SB
# reads % # reads % # reads % # reads % # reads %
Total reference length 114,183 220,003 115,372 222,532 254,658
Mapped reads 8,341,236 91.1 8,604,424 95.9 1,028,479 2.7 1,737,127 5.2 504,510 5.8
Unmapped reads 814,824 8.9 370,790 4.1 37,166,207 97.3 31,564,383 94.8 8,227,736 94.2
Reads in pairs 8,327,110 91.0 8,594,722 95.8 960,578 2.5 1,714,062 5.2 498,152 5.7
Broken paired reads 14,126 0.2 9,702 0.1 67,901 0.2 23,065 0.1 6,358 0.1
Total number of reads 9,156,060 8,975,214 38,194,686 33,301,510 8,732,246
Total read length (Mb) 915.6 897.5 3,819.5 3,330.2 873.2
Fraction of reference covered 1.00 1.00 1.00 1.00 1.00
Minimum coverage 241 125 28 22 6
Maximum coverage 15147 5631 2211 1514 574
Average coverage 7100.7 3812.3 851.5 752.2 191.0
Reads obtained from the Illumina Genome Analyzer IIx were analyzed and mapped to each reference sequence using CLC Genomics Workbench 5.5 (CLC Bio).
The number of mapped reads in each sample was enough to evaluate mutations. Analyzed DNA samples are follows: original BAC clones of BAC1 and BAC2 and
BGM clones of Tg110CIBS, Tg220CISP and Tg250SB.
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regulation mechanisms and disease research [3,25,26].
However, the BGM vector system has not yet been ap-
plied to transgenesis. Thus, we attempted to generate
transgenic mice carrying the modified and reconstructed
transgenes, Tg-110 and Tg-250SB, to demonstrate the
potency of the BGM vector system in transgenesis
(Figure 6). In contrast to other systems, the BGM vector
system utilizes the entire endogenous genome as a vec-
tor. Therefore, the transgene can be obtained by
digesting the genome with I-PpoI, whose recognition
sites are introduced to flank the BAC vector sequence
(Figure 1A). But its concentration is expected to be low
because of the single copy of the transgene per genome/
cell. Thus, we prepared linearized transgenes by excision
from the BGM vector using I-PpoI digestion and CHEF
and concentrated the transgenes by conventional elec-
trophoresis followed by electroelution and dialysis with a
high-salt injection buffer (Figure 6A). Using the method
established in this study, linearized microinjection-grade
transgenes were readily prepared from the BGM clones.
The purified transgenes were microinjected into fertil-
ized mouse eggs to obtain founder transgenic mice. New
born mice were genotyped by PCR to amplify transgene-
specific sequences. We designed three primer sets to
amplify BAC vector sequences (left and right end of the
transgene) and EGFP (middle of the transgene) to assess
the integration of the transgene into chromosome. As-
suming that all three PCR positive mouse would carry
an intact transgene, we obtained six Tg-110 founders
from 45 newborn mice. Partial integrations of the trans-
gene were also observed in 2 mice, which were PCR
positive for the left end of the transgene only. For Tg-
250SB, four of 26 pups carried an intact transgene, andone lacked the left end sequence. These transgenic ratios
are comparable to a conventional BAC transgenesis [3].
Germline transmission of the transgenes was obtained in
5 transgenic founders for Tg-110 (from 6 founders) and
two for Tg-250SB (from 4 founders).
Experimental evidence of a cis-acting element for a class I
OR gene
An individual olfactory sensory neuron (OSN) expresses
only one OR gene in a monoallelic and mutually exclu-
sive manner [27]. Class I ORs are expressed almost
exclusively by OSNs in the dorsal main olfactory epithe-
lium (MOE), and these OSNs project their axons to a
specific subset of glomeruli in the dorsal domain of the
olfactory bulb (OB) [28,29]. The transgenes of the
MOR42-3 locus are designed to activate the bicistronic
expression of MOR42-3 and tauEGFP, a fusion of the
microtubule-associated protein tau with EGFP, to
visualize the MOR42-3 transgene expression and OSN
axonal projections. Thus, if the transgenes contain a
MOR42-3 cis-acting element, MOR42-3 expression can
be monitored by EGFP fluorescence. For Tg-110, we
analyzed 5 transgenic lines and 1 founder. None of the
Tg-110 transgenic mice displayed labeled OSNs. For Tg-
250SB, two transgenic lines established from two founders
were EGFP positive (Figure 6B), indicating expression of
MOR42-3 transgene. Remaining two founders were EGFP
negative. Whole-mount images of the MOE and the OB
of Tg-250SB showed a punctate EGFP expression pattern
within the dorsal region of the MOE and axonal projec-
tions into the dorsomedial and dorsolateral glomerulus of
each OB (Figure 6C and E). To assess the copy number
and integrity of the transgene, we analyzed Tg-250SB by
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Figure 6 Generation of transgenic mice and expression of the EGFP reporter gene. (A) The quality and yield of the purified transgenes for
microinjection were confirmed by CHEF. All signals indicate intact fragments and sufficient amounts for microinjection. The concentration of
retrieved transgenes ranged from 0.3 to 3 ng/μl. (B) Schematic diagram of Tg-110 and Tg-250SB. Tg-250SB transgenic mice express the EGFP
reporter gene, whereas Tg-110 transgenic mice do not. The number of EGFP-positive independent founders and lines among the total analyzed
is shown in parentheses. (C) Whole-mount images of the medial aspect of the OB in transgenic Tg-110 (line #10, left panel) and Tg-250SB mice
(line #8, medial panel) and the MOR42-1-iTG [28] gene-targeted mouse (right panel). Tg-110 transgenic mice do not show EGFP fluorescence,
whereas Tg-250SB transgenic mice do. EGFP-labeled axons in Tg-250SB converge on the dorsal side of the OB and form a glomerulus.
Arrowheads indicate glomeruli. D, dorsal; V, ventral; A, anterior; P, posterior. (D) Southern blot analysis of Tg-250SB line #8 and its transgene-
negative littermate (control). The MOR42-3 probe detected the endogenous (2.0 kb, open arrowhead) and the transgenic (1.2 kb, closed
arrowhead) MOR42-3 genes, and also detect both endogenous and transgenic MOR42-1 gene (13.6 kb, arrow). (E) Confocal images of Tg-250SB
line #8 transgenic and MOR42-1-iTG gene-targeted mice. Mosaic patterns of EGFP-expressing OSNs in the dorsal epithelium (medial view, left
panel) and glomeruli formed by axons in the OB (dorsal view, right panel) were observed. (F) Tg-MOR42-3 (left panel) or endogenous-MOR42-1
glomeruli (right panel) were detected by immunostaining coronal cryosections. Red, OMP immunoreactivity. Green, EGFP immunoreactivity. Blue,
DAPI nuclear staining, which marks the glomeruli structure. The glomeruli in the Tg-250SB transgenic mouse showed an intermingling of red
(EGFP-negative) and yellow (EGFP-positive) axons, whereas the glomeruli in the homozygous MOR42-1-iTG mouse were fully doubly labeled.
Scale bars: E, 500 μm; F, 30 μm.
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gene MOR42-1 (97% identical). Southern blot analysis
showed that the specific band corresponding to the trans-
gene was observed in expected size and the bands corre-
sponding to endogenous MOR42-3 were the same
between control and Tg-250SB, indicating that the intact
transgenes were integrated into chromosome, and this is
not due to a gene targeting event. Ratio of signal inten-
sities (transgene/endogenous gene) were 1.05 for line #5
(n = 1) and 0.46 ± 0.02 for line #8 (n = 4), indicating the
copy number of transgene of two and one for line#5 and
line#8, respectively. Because the Tg-250SB transgene car-
ries MOR42-1, intensities of the band corresponding to
MOR42-1 increased 1.61 ± 0.18 fold in Tg-250SB line #8
with reference to the control, confirming one copy of the
transgene was integrated.
OSNs expressing highly homologous ORs tend to pro-
ject their axons to near but distinct subsets of glomeruli
in the OB [30]. Because MOR42-3 and MOR42-1, mem-
bers of the MOR42 subfamily, share 97% amino acid
similarity in their coding sequences, the axonal projec-
tion site of MOR42-3-expressing OSNs was expected to
be close to that of MOR42-1. Using axonal projection of
OSNs expressing endogenous MOR42-1 as control, we
examined the MOR42-1-iTG gene-targeted mouse [28]
in which an IRES-tauEGFP reporter was inserted down-
stream of MOR42-1. The glomerular positions of
transgenic-MOR42-3 (Tg-MOR42-3) in Tg-250SB trans-
genic mice were similar to those of endogenous
MOR42-1 (Figure 6C, E). We further analyzed the de-
tailed structure of the Tg-MOR42-3 glomeruli. Glom-
eruli are innervated exclusively by axons from OSNs
expressing the same OR [31]. We performed double-
label immunohistochemistry on coronal cryosections
with antibodies against olfactory marker protein (OMP)
to stain all mature OSN and antibodies against EGFP to
label MOR42-3 transgene- or MOR42-1 endogenous gene-
expressing OSNs. Tg-MOR42-3 glomeruli contained a mix-
ture of EGFP-negative and EGFP-positive axons, whereas
MOR42-1 glomeruli of homozygous MOR42-1-iTG mice
were completely EGFP positive (Figure 6F), suggesting that
axons of OSNs expressing Tg-MOR42-3 formed glomeruli
together with those of OSNs expressing endogenous
MOR42-3 [32]. The projection site and converged glomeru-
lar structure of OSNs expressing the EGFP reporter suggest
proper expression of the MOR42-3 transgene. Taken
together, these results indicate that a cis-acting element for
MOR42-3 is present in the extended region from Tg-110
and provide the first experimental evidence of a cis-acting
element for a class I OR gene.
Discussion
The BGM vector system is a unique and developing
technology for propagation of very large fragments ofheterologous DNA. In this study, we have demonstrated
that the BGM vector system enables the complete
genetic modification of large genomic DNA fragments,
including targeted insertion, deletion, inversion and
fusion. In addition, we demonstrated the existence of a
cis-acting element of a mouse class I OR gene by com-
bining the BGM vector system with mouse transgenesis.
The BGM vector has several specific features that cre-
ate advantages over the BAC and YAC systems. First,
the megabase-scale cloning capacity of the BGM vector
is greater than that of conventional systems. The BGM
vector system is capable of cloning the entire 3.5 Mb
Synechocystis genome [15], and the upper limit of clone
size has not yet been determined. Second, cloned DNA
inserts show high structural and genetic stability [10] be-
cause of their direct insertion into the single circular
host genome. In fact, DNA sequencing of modified and
reconstructed genomic DNA fragments confirmed the
structural stability of inserts in the BGM vector even
though genome inserts included many repetitive se-
quences and several similar class I OR genes. However,
it should be noted that, similar to the YAC system, re-
combination is active in B. subtilis; thus, unwanted
rearrangements may occur. This issue can be solved by
introducing an inducible RecA system into the BGM
vector. Third, various accurate modification approaches
are available. The cI repressor cassette-mediating modifi-
cation technique provides desired gene modifications
without leaving any traces in the DNA, enabling the
repetitive modification of BGM inserts. In addition to
insertion and deletion modifications, we demonstrated
the elongation of inserts via the fusion of two DNA frag-
ments even though they were initially oriented in oppos-
ite directions in the BAC vector, thus providing a
method for the construction of giant recombinant DNA
fragments. Considering with maximum cloning capacity
of the BGM vector of 3 Mbp [15], the fusion of contigu-
ous genomic fragments is a powerful technique for the
reconstruction of gene structures surrounding intergenic
regulatory elements [16,33]. In addition, our sequencing
analyses confirmed that these targeted genetic modifica-
tions were accurate and reliable. Fourth, BGM inserts
can be simply retrieved by I-PpoI digestion because a
single host cell contains a single genome composed of
the recombinant insert and the 4.2 Mb BGM vector. As
we demonstrated, BAC clones are easily transferred,
modified and reconstructed in the BGM vector. It is
noteworthy that modified BGM inserts can be restored
to a circular BAC form [10], enabling this “shuttle gen-
etic modification” of BAC clones to enhance the utility
of BGM vector system.
Finally, we have used mouse genomic DNA to demon-
strate the suitability of the BGM system for genetic ma-
nipulation and transgenesis. Many BAC libraries have
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for diverse species, including mammals, other verte-
brates and plants [34]. Because the BGM vector harbors
BAC vector sequences for cloning BAC inserts, this sys-
tem can be applied to other species. Moreover, the BGM
vector can be designed to clone other library resources
by introducing cloning vector sequences from other sys-
tems, e.g., YACs and human artificial chromosomes. Be-
cause the BGM vector system can provide large cloning
capacity in size and various accurate gene manipulation
approaches, the BGM vector system is an attractive clon-
ing tool for the manipulation of large DNA fragments,
such as in the functional analysis of genomic DNA and re-
combinant genomes in synthetic biology [9,35].
Conclusion
We demonstrated targeted insertion and inversion
methods in the BGM system to add to its repertoire of
genetic modification approaches. Using these tech-
niques, a 252 kb transgene was reconstructed from two
BAC clones whose inserts were initially oriented in
opposite direction with reference to the BAC vector se-
quence. DNA sequence analysis of modified BGM clones
demonstrated the genetic stability of inserts and correct
modifications. Furthermore, we established and applied
BGM-based mouse transgenesis. By analyzing the gener-
ated transgenic mice, a cis-acting element for a mouse
class I OR gene was experimentally demonstrated for
the first time. The BGM vector is a new platform that
provides a complete genetic modification approach for
large genomic DNA fragments without leaving selection
markers or dispensable sequences. The BGM vector sys-
tem and its application to transgenesis offer a new gen-
etic approach for not only systems and synthetic biology
but also other life science research fields.
Methods
Strains and preparation of competent B. subtilis
The B. subtilis strains and the BAC-specific BGM vec-
tors BEST310 and BEST6528 [10,16] were kindly pro-
vided by Dr. Itaya. These strains are derived from the
restriction modification-deficient strain RM125 to pos-
sess a cI repressor gene cassette flanked by pBAC108-
based BAC vector sequences [1,10] and are identical
with the exception that BEST6528 contains a 100 kb
spacer sequence and an additional cI repressor gene cas-
sette [16]. For defining insert orientation, the half of the
BAC vector containing the chloramphenicol resistance
gene for E.coli is defined as right side (open arrows in
Figures). The preparation of competent cells and trans-
formation of B. subtilis were performed as described
elsewhere [12]. Strains containing multiple antibiotic-
resistance genes were tested using the replica plating
method. B. subtilis was routinely grown in 1–5 mlLuria-Bertani (LB) broth at 37°C by rotating (>50 rpm)
or shaking (200 rpm). Antibiotic Medium 3 (Difco) was
used for the selection of the BGM transformants with
the following antibiotics, as appropriate: neomycin (Nm,
5 μg/ml, Sigma), spectinomycin (Spc, 50 μg/ml, Sigma),
erythromycin (Em, 5 μg/ml, Sigma), phleomycin (Phl,
0.5 μg/ml, Sigma), tetracycline (Tet, 10 μg/ml, Nacalai)
and blasticidin S (Bs, 250 μg/ml, Funakoshi).
One-step transfer of BAC inserts to the BGM vector
Two contiguous BAC clones, RP24-392H7 and RP23-
61O11 (designated BAC1 and BAC2, respectively), were
purchased from the Children’s Hospital Oakland Research
Institute. The BAC DNA was prepared by the alkaline
lysis method and subsequent equilibrium centrifugation
in a CsCl-ethidium bromide gradient [17]. BGM strains
were transformed with the purified BAC DNAs [10].
BAC1 and BAC2 were cloned into BEST310 and
BEST6528, respectively.
I-PpoI/CHEF analysis
The cloned inserts in the BGM vectors were analyzed by
I-PpoI digestion followed by CHEF electrophoresis.
Agarose plugs containing BGM clones were prepared as
described [12]. A sliced block of the agarose plug was
soaked in 200 μl of I-PpoI digestion buffer for 15 min to
replace the TE buffer in the agarose plug. After
discarding the soaking buffer, the block was immersed in
100 μl of digestion buffer containing 20 U of I-PpoI
(Promega) and incubated for 1–1.5 hours at 37°C. The
plug containing the digested DNA was embedded in a
well of a 1% (w/v) agarose gel and separated by CHEF
(Bio Craft) in 0.5 × TBE buffer (50 mM Tris–borate
(pH 8.0), 1.0 mM EDTA). Electrophoresis was
performed at 4 V/cm at 14°C under the following condi-
tions: 12 sec for 21 h (BAC1, Tg-110), 30 sec for 22 h
(BAC2, Tg-220) and 25 sec for 22 h (Tg-250SB).
Southern blot analysis of the BGM clones
Genomic DNA from the BGM clones was prepared
using the liquid isolation method [12]. The genomic
DNA was digested with EcoRI, HindIII or BamHI
(TaKaRa). The digested DNA was separated in pulse-
field gels at 3 V/cm, 18 sec for 14 h at 14°C, and the
DNA was transferred onto a Hybond-N (GE Healthcare)
membrane filter. The preparation of digoxigenin (DIG)-
labeled DNA probes, Southern hybridization and detec-
tion with NBT/BCIP were performed using a DNA
labeling and detection kit (Roche).
Construction of plasmids
To construct the reporter cassette insertion plasmid, a
linker containing AscI, SpeI, BglII, NdeI and SphI sites
was inserted between the XbaI and SacI sites of
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vector. An EcoRI-XbaI fragment of IRES-tauEGFP from
the iTGFP-ACNF plasmid [23] was cloned into pT1 to
generate pT1-iTGFP. The 1.0 kb left (L) and right 1.0 kb
(R) arms for the targeted insertion of IRES-tauEGFP into
the 3 bp downstream of the MOR42-3 stop codon were
prepared by PCR and contained sequences that were
homologous to the upstream and downstream MOR42-3
insertion sites, respectively. The L arm was first cloned
into the SalI-EcoRI site of pT1-iTGFP, and then the R
arm was cloned into the SpeI-BglII site to generate the
plasmid piTG423. The piTG423-CISP plasmid was
constructed by inserting a selection marker-containing
the cI-spc cassette into the AscI-SpeI site of the piTG423
plasmid.
To construct the inversion plasmid, the new BAC plas-
mid p108IPpoI-HPNSB was generated by inserting a linker
containing PmlI, NotI and SphI sites between the HindIII
and BamHI sites of the BAC plasmid p108NHBN-MIM
[10]. The te-erm cassette, which was obtained from a NotI-
digested fragment from pBEAZ191 [24], was inserted into
the PmlI site of this plasmid after blunt-end treatment to
generate the plasmid p108Term. Similarly, the phl-et
cassette, a NotI fragment from pBEAZ195 [24], was
inserted to generate the plasmid p108Phlet. A 0.9 kb frag-
ment homologous to the left end of Tg-110 was cloned
into the NotI site of p108Term. A 0.8 kb fragment hom-
ologous to the right side of Tg-110 (1.3 kb from the right
end) was then cloned into the HindIII site of p108Phlet.
Fusion plasmids were also constructed based on
p108IPpoI-HPNSB. The p108CISP plasmid was constructed
by inserting the cI-spc cassette, a HindIII-BamHI fragment
excised from pCISP310B, into the PmlI site after blunt-
ending. Similarly, p108CIBS was constructed by cloning the
cI-bsr cassette, a PstI fragment derived from pBEST10007.
A 1.3 kb PCR fragment homologous to the left end of Tg-
220 was cloned into the NotI site of p108CISP, and a 1.3 kb
fragment homologous to the right end of the inverted Tg-
110 was cloned into the MluI site of p108CIBS.
All of the plasmids were linearized with the appropriate
restriction enzymes (TaKaRa or Toyobo) and used for trans-
formation. The all homologous arms (approximately 1 kb)
and cI-spc cassette were amplified by PCR (PrimeSTAR HS
DNA polymerase, TaKaRa, or KOD plus DNA polymerase,
Toyobo) using the BAC clones and pCISP310B [10] as tem-
plates, respectively. Primer sequences and PCR conditions
are summarized in Additional file 2. The orientations of the
inserts were determined by restriction enzyme digestion or
PCR. The accuracy of the sequences generated by PCR was
confirmed by DNA sequencing.
DNA sequencing
Sequences of the original BAC and modified BGM
clones (Tg-110CIBS, Tg-220CISP and Tg-250SB) wereverified using next-generation sequencing. Briefly, gen-
omic DNA (3 μg) from the above clones was fragmented
to an average length of 300 bp using the Covaris S2 sys-
tem (Covaris). After purification, end-repairing, A-tailing,
paired-end adapter ligation and 12-cycle PCR were
performed using the NEBNext DNA Library Prep Master
Mix Set and NEBNext Multiplex Oligos for Illumina (New
England Biolabs). All libraries were quantified using an
Agilent Bioanalyzer 2100 (Agilent Technologies) and
pooled to provide equal genome coverage from each li-
brary. Pooled libraries were sequenced in a single lane of
the Illumina Genome Analyzer IIx (Illumina), which pro-
duced 102 paired-end reads, in accordance with the man-
ufacturer’s instructions.
Reads obtained from the Illumina Genome Analyzer
IIx were analyzed using CLC Genomics Workbench 5.5
(CLC Bio). Reads were trimmed and mapped to each
reference sequence with default parameters. The refer-
ence sequences used in this study included the following:
BAC1, original BAC clone RP24-392H7 [GenBank:
AC132096]; BAC2, original BAC clone RP23-61O11
[GenBank: AC102535]; B1TgCIBS and B2TgCISP, pre-
dicted modified mouse genomic Tg-110CIBS and Tg-
220CISP insert sequences; and Tg250SB, a predicted
fused mouse genomic Tg-250SB insert sequence. The
mapping results are detailed in Table 1. After mapping
the reads, variant calling was performed using the prob-
abilistic variant detection function with default parame-
ters, and variants with frequencies of at least 90% were
considered. All read data have been deposited in the
DDBJ Sequence Read Archive (DRA) under accession
number [DRA000859].
Preparation of the transgenes for pronuclear injection
Genomic DNA carrying the transgene in an agarose plug
was prepared, digested with I-PpoI and resolved by
CHEF in a 1% (w/v) agarose gel using sterile 0.5 × TBE,
as performed for the I-PpoI analysis. To concentrate the
transgene fragment, the band was excised from the agar-
ose gel, turned vertically and embedded in 4% (w/v)
agarose; electrophoresis was then performed at 3.3 V/cm
for more than 10 hours in 0.5 × TBE. The excised con-
centrated transgene band was placed in a prepared dialy-
sis tube hydrated with 0.5 × TBE, and the transgene was
electroeluted from the gel under the same conditions.
The eluate was dialyzed with injection buffer (10 mM
Tris–HCl (pH 8.0), 0.1 mM EDTA, 100 mM NaCl) at 4-
6°C overnight. The concentration and integrity were es-
timated based on the control band intensity in the CHEF
analysis. The purified transgenes were used immediately.
Alternatively, 75 μM spermidine and 30 μM spermine
were added for long-term storage. The stock transgenes
were diluted to 0.3-1.5 ng/μl with injection buffer before
use.
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The purified transgenes were microinjected into the pro-
nucleus of B6C3F1 (C3H/HeSlc male × C57BL/6NCrSlc
female) mouse zygotes. Injected eggs were transferred to
the oviducts of pseudopregnant female ICRs. The foun-
ders were screened by PCR with the following three pri-
mer sets that specifically amplified the internal and left
and right ends of the transgenes: EGFP: GFP-F, 5′-
GGCATCAAGGTGAACTTCAAGATCC-3′ and GFP-R,
5′-CTTTACTTGTACAGCTCGTCCATGC-3′; the left
end of the BAC sequence: SacB-F, 5-GCTGAATACAACG
GCTATCACG-3′ and SacB-R, 5′-TCTCTCAGCGTAT
GGTTGTCG-3′, or BAC108 L-F, 5′-CGTATTCAGTGT
CGCTGATTTG-3′ and BAC108 L-R, 5′-TTAGCGATG
AGCTCGGACTTC-3′; and for the right end of the BAC
sequence: CmR-F, 5′-GAGGCATTTCAGTCAGTTGC
TC-3′ and CmR-R, 5′-CGGCATGATGAACCTGAAT
CG-3′. All founder mice positive for these three primer
sets were selected as candidates containing intact
transgenes. The founder mice were crossed with C57BL/6
mice. The transgenic mice were dissected and fixed in 4%
paraformaldehyde (PFA)/PBS for 10–15 min on ice. Line
8 of two EGFP-expressing Tg-250SB transgenic lines was
used for the expression analyses in Figure 6.
For Southern blot analysis, 10 μg of genomic DNA
extracted from a tail was digested with EcoRI (TaKaRa)
and separated on a 1% agarose gel. The DNA was
transferred onto a membrane filter, and hybridized
with a DIG-labeled MOR42-3 coding probe (nucleotides
190 – 1091 from NM_020289). The signals were detected
by chemiluminescence (CSPD, Roche) using a CCD
camera (ChemiDoc™ XRS, Bio-Rad). The copy numbers
were estimated by comparing the intensities of transgenic
and endogenous signals.
For immunohistochemistry (IHC), mice were fixed by per-
fusion with 4% PFA/PBS and infiltration in the same fixative
solution at 4°C for 30 min. After cryoprotection with 15%
and 30% sucrose/PBS, tissues were embedded in Frozen
Section Compound (Surgipath FSC22, Leica microsystems).
Serial cryosections (20 μm) were collected on MAS-coated
microscope glass slides (Matsunami) and dried for 1 h at
room temperature. IHC was performed by a standard proto-
col [36]. After post-fixation, permeabilization and antigen-
retrieval pretreatment, sections were blocked with 10%
normal horse serum and incubated with primary antibody
at 4°C overnight. The following primary antibodies and dilu-
tions were used: rat anti-GFP (1:2000, catalog #04404-84,
Nacalai) and goat anti-OMP (1:5000, catalog #544-10001,
Wako). After incubation of the primary antibodies, sections
were washed in PBS containing 0.01% Tween 20 and stained
by the following Alexa Fluor-conjugated secondary anti-
bodies (1:500, Invitrogen): Alexa Fluor 488-conjugated don-
key anti-rat IgG and Alexa Fluor 546-conjugated donkey
anti-goat IgG. Nuclear staining was performed with DAPI(1:1000, Vector Laboratories), and CC/Mount (Diagnostic
BioSystems) was used for mounting.
Fluorescent images of endogenous GFP and IHC signals
were taken with Olympus SZX10 fluorescent stereomicro-
scope with a DP71 digital CCD camera and Leica SPE
confocal microscope. Confocal images were collected as
z-stacks and projected into a single image for display.
Images were analyzed and adjusted using Photoshop CS4
(Adobe). All of the mouse studies were approved by the
Institutional Animal Experiment Committee of the Tokyo
Institute of Technology and performed in accordance with
institutional and governmental guidelines.
Additional files
Additional file 1: Efficiency of cloning BAC inserts into the BGM
vector. This file contains the efficiency of cloning BAC clones into the
BGM vector: clone names and ID, length of BAC inserts, BGM vector used
for cloning and the numbers of tested and insert-positive clones.
Additional file 2: Primer sequences and PCR conditions. This file
contains information of all primer sequences and PCR conditions used in
this study for constructing homology arms, cassettes and new BAC
plasmid, screening of BGM clones and genotyping.
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